<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font18 { font-size : 18; } .font20 { font-size : 20; } .font10 { font-size : 10; } .font27 { font-size : 27; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; }</style>
 <body>
  <p>
   <span class="font30">and </span>
   <span class="font27">the </span>
   <span class="font20">al., </span>
   <span class="font18">(). </span>
   <span class="font16">with </span>
   <span class="font14">for </span>
   <span class="font14">al. </span>
   <span class="font14">that </span>
   <span class="font13">The </span>
   <span class="font13">SARS-CoV </span>
   <span class="font13">antiviral </span>
   <span class="font12">viral </span>
   <span class="font12">SARS-CoV- </span>
   <span class="font12">are </span>
   <span class="font12">against </span>
   <span class="font12">clinical </span>
   <span class="font12">treatment </span>
   <span class="font12">patients </span>
   <span class="font12">coronavirus </span>
   <span class="font12">Î¼M </span>
   <span class="font11">activity </span>
   <span class="font11">severe </span>
   <span class="font11">was </span>
   <span class="font11">respiratory </span>
   <span class="font11">from </span>
   <span class="font11">not </span>
   <span class="font11">compounds </span>
   <span class="font11">replication </span>
   <span class="font11">virus </span>
   <span class="font11">cells </span>
   <span class="font11">vivo </span>
   <span class="font11">this </span>
   <span class="font11">have </span>
   <span class="font11">vitro </span>
   <span class="font11">drug </span>
   <span class="font11">COVID- </span>
   <span class="font11">these </span>
   <span class="font11">which </span>
   <span class="font11">(EC </span>
   <span class="font11">but </span>
   <span class="font11">assays </span>
   <span class="font11">been </span>
   <span class="font11">human </span>
   <span class="font11">infection </span>
   <span class="font11">also </span>
   <span class="font11">syndrome </span>
   <span class="font11">were </span>
   <span class="font11">acute </span>
   <span class="font11">can </span>
   <span class="font11">protein </span>
   <span class="font11">its </span>
   <span class="font11">such </span>
   <span class="font11">{background </span>
   <span class="font10">MERS-CoV </span>
   <span class="font10">host </span>
   <span class="font10">other </span>
   <span class="font10">potential </span>
   <span class="font10">Entry </span>
   <span class="font10">drugs </span>
   <span class="font10">Î¼g </span>
   <span class="font10">effect </span>
   <span class="font10">effects </span>
   <span class="font10">entry </span>
   <span class="font10">has </span>
   <span class="font10">might </span>
   <span class="font10">CoVs </span>
   <span class="font10">highly </span>
   <span class="font10">studies </span>
   <span class="font10">RNA </span>
   <span class="font10">inhibited </span>
   <span class="font10">molecule, </span>
   <span class="font10">CoV </span>
   <span class="font10">However, </span>
   <span class="font10">viruses </span>
   <span class="font10">Replication </span>
   <span class="font10">Res.â€". </span>
   <span class="font10">Synthetic </span>
   <span class="font10">This </span>
   <span class="font10">Vero </span>
   <span class="font10">authors </span>
   <span class="font10">chloroquine </span>
   <span class="font10">easily </span>
   <span class="font10">improved </span>
   <span class="font10">infected </span>
   <span class="font10">inhibition </span>
   <span class="font10">margin </span>
   <span class="font10">results </span>
   <span class="font10">tolerated, </span>
   <span class="font10">trials </span>
   <span class="font10">Coronavirus </span>
   <span class="font10">Med. </span>
   <span class="font10">SARS </span>
   <span class="font10">activities </span>
   <span class="font10">described </span>
   <span class="font10">related </span>
   <span class="font10">showed </span>
   <span class="font10">{border-style </span>
   <span class="font10">associated </span>
   <span class="font10">compound </span>
   <span class="font10">effective </span>
   <span class="font10">into </span>
   <span class="font10">there </span>
   <span class="font10">ACE </span>
   <span class="font10">Virol.â€". </span>
   <span class="font10">demonstrated </span>
   <span class="font10">presented </span>
   <span class="font10">proteins </span>
   <span class="font10">px;} </span>
   <span class="font10">their </span>
   <span class="font10">therapy </span>
   <span class="font10">used </span>
   <span class="font10">#ffffff;} </span>
   <span class="font10">&amp;gt; </span>
   <span class="font10">animal </span>
   <span class="font10">cell </span>
   <span class="font10">study </span>
   <span class="font10">treat </span>
   <span class="font10">./j.antiviral... </span>
   <span class="font10">b). </span>
   <span class="font10">mLâ€" </span>
   <span class="font10">outcomes </span>
   <span class="font10">several </span>
   <span class="font10">since </span>
   <span class="font10">Î¼M) </span>
   <span class="font10">Clinical </span>
   <span class="font10">efficacy </span>
   <span class="font10">important </span>
   <span class="font10">inhibitor </span>
   <span class="font10">may </span>
   <span class="font10">patients, </span>
   <span class="font10">produced </span>
   <span class="font10">some </span>
   <span class="font10">when </span>
   <span class="font10">./s--- </span>
   <span class="font10">antibody </span>
   <span class="font10">broad-spectrum </span>
   <span class="font10">cells, </span>
   <span class="font10">disease </span>
   <span class="font10">immune </span>
   <span class="font10">plasma </span>
   <span class="font10">spike </span>
   <span class="font10">trial </span>
   <span class="font10">Î¼M), </span>
   <span class="font10">â€" </span>
   <span class="font10">Chloroquine </span>
   <span class="font10">Infect. </span>
   <span class="font10">SARS-CoV, </span>
   <span class="font10">and/or </span>
   <span class="font10">development </span>
   <span class="font10">did </span>
   <span class="font10">different </span>
   <span class="font10">further </span>
   <span class="font10">hydroxychloroquine </span>
   <span class="font10">inhibit </span>
   <span class="font10">inhibitors </span>
   <span class="font10">possible </span>
   <span class="font10">potent </span>
   <span class="font10">Available </span>
   <span class="font10">Inhibited </span>
   <span class="font10">MHV </span>
   <span class="font10">at: </span>
   <span class="font10">during </span>
   <span class="font10">feline </span>
   <span class="font10">lacks </span>
   <span class="font10">novel </span>
   <span class="font10">online </span>
   <span class="font10">promising </span>
   <span class="font10">ribavirin </span>
   <span class="font10">use </span>
   <span class="font10">well </span>
   <span class="font10">(a). </span>
   <span class="font10">(b). </span>
   <span class="font10">Dis.â€". </span>
   <span class="font10">Inhibition </span>
   <span class="font10">Med.â€". </span>
   <span class="font10">adverse </span>
   <span class="font10">based </span>
   <span class="font10">caused </span>
   <span class="font10">coronaviruses </span>
   <span class="font10">emerging </span>
   <span class="font10">inhibits </span>
   <span class="font10">mice </span>
   <span class="font10">molecules </span>
   <span class="font10">peptide </span>
   <span class="font10">suggested </span>
   <span class="font10">symptoms </span>
   <span class="font10">Acad. </span>
   <span class="font10">HCoV-E </span>
   <span class="font10">HCoV-NL </span>
   <span class="font10">Ivermectin </span>
   <span class="font10">Natl. </span>
   <span class="font10">These </span>
   <span class="font10">both </span>
   <span class="font10">candidates </span>
   <span class="font10">collab: </span>
   <span class="font10">conducted </span>
   <span class="font10">could </span>
   <span class="font10">due </span>
   <span class="font10">enzyme </span>
   <span class="font10">infections </span>
   <span class="font10">most </span>
   <span class="font10">new </span>
   <span class="font10">protease </span>
   <span class="font10">receptor </span>
   <span class="font10">targeting </span>
   <span class="font10">./JVI.- </span>
   <span class="font10">./S-()- </span>
   <span class="font10">./pnas. </span>
   <span class="font10">COVID-: </span>
   <span class="font10">Chem.â€". </span>
   <span class="font10">Drug </span>
   <span class="font10">Lopinavir </span>
   <span class="font10">Sci. </span>
   <span class="font10">able </span>
   <span class="font10">activity, </span>
   <span class="font10">assessed </span>
   <span class="font10">cause </span>
   <span class="font10">context, </span>
   <span class="font10">data </span>
   <span class="font10">designed </span>
   <span class="font10">genome </span>
   <span class="font10">good </span>
   <span class="font10">interaction </span>
   <span class="font10">monoclonal </span>
   <span class="font10">more </span>
   <span class="font10">produced, </span>
   <span class="font10">therapeutic </span>
   <span class="font10">using </span>
   <span class="font10">Additionally, </span>
   <span class="font10">Agents </span>
   <span class="font10">MERS-CoV, </span>
   <span class="font10">Microbiol.â€". </span>
   <span class="font10">Therefore, </span>
   <span class="font10">Tocilizumab </span>
   <span class="font10">[Preprint]./... </span>
   <span class="font10">analog </span>
   <span class="font10">between </span>
   <span class="font10">candidate </span>
   <span class="font10">convalescent </span>
   <span class="font10">cytokine </span>
   <span class="font10">diseases </span>
   <span class="font10">evaluated </span>
   <span class="font10">family </span>
   <span class="font10">had </span>
   <span class="font10">hepatitis </span>
   <span class="font10">impairing </span>
   <span class="font10">px; </span>
   <span class="font10">reduced </span>
   <span class="font10">structural </span>
   <span class="font10">structure </span>
   <span class="font10">{font-family </span>
   <span class="font10">Î¼M, </span>
   <span class="font10">â€". </span>
   <span class="font10">(NCT), </span>
   <span class="font10">./AAC.- </span>
   <span class="font10">Another </span>
   <span class="font10">COVID-. </span>
   <span class="font10">Chemother.â€". </span>
   <span class="font10">CoVs, </span>
   <span class="font10">East </span>
   <span class="font10">Host </span>
   <span class="font10">Kim </span>
   <span class="font10">Middle </span>
   <span class="font10">Moreover, </span>
   <span class="font10">NAAE </span>
   <span class="font10">Rev. </span>
   <span class="font10">U.S.A.â€". </span>
   <span class="font10">a). </span>
   <span class="font10">among </span>
   <span class="font10">antivirals </span>
   <span class="font10">association </span>
   <span class="font10">binding </span>
   <span class="font10">cathepsin </span>
   <span class="font10">cells. </span>
   <span class="font10">combination </span>
   <span class="font10">derivatives </span>
   <span class="font10">font-size </span>
   <span class="font10">improve </span>
   <span class="font10">infectious </span>
   <span class="font10">information </span>
   <span class="font10">interference </span>
   <span class="font10">lack </span>
   <span class="font10">main </span>
   <span class="font10">mild </span>
   <span class="font10">multiple </span>
   <span class="font10">only </span>
   <span class="font10">process </span>
   <span class="font10">provide </span>
   <span class="font10">replication, </span>
   <span class="font10">resistance </span>
   <span class="font10">response </span>
   <span class="font10">review </span>
   <span class="font10">seems </span>
   <span class="font10">shown </span>
   <span class="font10">support </span>
   <span class="font10">target </span>
   <span class="font10">type </span>
   <span class="font10">vaccine </span>
   <span class="font10">(Kim </span>
   <span class="font10">./----_ </span>
   <span class="font10">Antiviral </span>
   <span class="font10">Broad-spectrum </span>
   <span class="font10">CLpro </span>
   <span class="font10">FIPV </span>
   <span class="font10">For </span>
   <span class="font10">HIV </span>
   <span class="font10">Hydroxychloroquine </span>
   <span class="font10">J.et </span>
   <span class="font10">Mol. </span>
   <span class="font10">Remdesivir </span>
   <span class="font10">Ritonavir </span>
   <span class="font10">SARS-CoV-, </span>
   <span class="font10">SARS-CoV-. </span>
   <span class="font10">Structural </span>
   <span class="font10">Wilde </span>
   <span class="font10">acid </span>
   <span class="font10">addition, </span>
   <span class="font10">alternative </span>
   <span class="font10">analogs </span>
   <span class="font10">bind </span>
   <span class="font10">case </span>
   <span class="font10">cellular </span>
   <span class="font10">concentration </span>
   <span class="font10">current </span>
   <span class="font10">cytotoxicity </span>
   <span class="font10">domain </span>
   <span class="font10">double-blind, </span>
   <span class="font10">double; </span>
   <span class="font10">early </span>
   <span class="font10">effects, </span>
   <span class="font10">emergence </span>
   <span class="font10">employing </span>
   <span class="font10">expression </span>
   <span class="font10">humans </span>
   <span class="font10">infect </span>
   <span class="font10">inhibiting </span>
   <span class="font10">interfere </span>
   <span class="font10">knowledge </span>
   <span class="font10">load </span>
   <span class="font10">lung </span>
   <span class="font10">mechanisms </span>
   <span class="font10">model </span>
   <span class="font10">phase </span>
   <span class="font10">post-entry </span>
   <span class="font10">present </span>
   <span class="font10">proteins. </span>
   <span class="font10">reducing </span>
   <span class="font10">regarding </span>
   <span class="font10">release </span>
   <span class="font10">rhesus </span>
   <span class="font10">risk </span>
   <span class="font10">siRNAs </span>
   <span class="font10">small </span>
   <span class="font10">stages </span>
   <span class="font10">than </span>
   <span class="font10">transmission </span>
   <span class="font10">treated </span>
   <span class="font10">trials, </span>
   <span class="font10">two </span>
   <span class="font10">(Huentelman </span>
   <span class="font10">(SARS-CoV-) </span>
   <span class="font10">(Sheahan </span>
   <span class="font10">(Table </span>
   <span class="font10">(Wang </span>
   <span class="font10">./jm </span>
   <span class="font10">./v </span>
   <span class="font10">Clin. </span>
   <span class="font10">CoVs. </span>
   <span class="font10">Comparative </span>
   <span class="font10">Cyclosporin </span>
   <span class="font10">Drugs </span>
   <span class="font10">Engl. </span>
   <span class="font10">FDA </span>
   <span class="font10">Finally, </span>
   <span class="font10">IFN-Î² </span>
   <span class="font10">Influenza </span>
   <span class="font10">Institute </span>
   <span class="font10">July </span>
   <span class="font10">June </span>
   <span class="font10">MA: </span>
   <span class="font10">Monoclonal </span>
   <span class="font10">NHC </span>
   <span class="font10">Other </span>
   <span class="font10">RNAs </span>
   <span class="font10">University </span>
   <span class="font10">Vaccine </span>
   <span class="font10">WHO </span>
   <span class="font10">WildeA. </span>
   <span class="font10">active </span>
   <span class="font10">administered </span>
   <span class="font10">after </span>
   <span class="font10">already </span>
   <span class="font10">and, </span>
   <span class="font10">antibodies </span>
   <span class="font10">assess </span>
   <span class="font10">azithromycin </span>
   <span class="font10">being </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">corticosteroids </span>
   <span class="font10">critical </span>
   <span class="font10">cycle </span>
   <span class="font10">date, </span>
   <span class="font10">days </span>
   <span class="font10">death </span>
   <span class="font10">decrease </span>
   <span class="font10">decreased </span>
   <span class="font10">derived </span>
   <span class="font10">dexamethasone </span>
   <span class="font10">disease, </span>
   <span class="font10">efficient </span>
   <span class="font10">employed </span>
   <span class="font10">envelope </span>
   <span class="font10">factors </span>
   <span class="font10">first </span>
   <span class="font10">function </span>
   <span class="font10">high </span>
   <span class="font10">hyperinflammation </span>
   <span class="font10">identified </span>
   <span class="font10">indicated </span>
   <span class="font10">induced </span>
   <span class="font10">influenza </span>
   <span class="font10">interferon </span>
   <span class="font10">mLâˆ’ </span>
   <span class="font10">mechanical </span>
   <span class="font10">membrane </span>
   <span class="font10">middle </span>
   <span class="font10">moderate </span>
   <span class="font10">mortality </span>
   <span class="font10">nonstructural </span>
   <span class="font10">nucleoside </span>
   <span class="font10">observed </span>
   <span class="font10">one </span>
   <span class="font10">outcome </span>
   <span class="font10">oxocarbazate </span>
   <span class="font10">pandemic </span>
   <span class="font10">peptides </span>
   <span class="font10">pneumonia </span>
   <span class="font10">possess </span>
   <span class="font10">previous </span>
   <span class="font10">rapid </span>
   <span class="font10">receptor-binding </span>
   <span class="font10">reduce </span>
   <span class="font10">relevant </span>
   <span class="font10">reported </span>
   <span class="font10">representing </span>
   <span class="font10">research </span>
   <span class="font10">respectively) </span>
   <span class="font10">responsible </span>
   <span class="font10">role </span>
   <span class="font10">side </span>
   <span class="font10">silico </span>
   <span class="font10">solid; </span>
   <span class="font10">specific </span>
   <span class="font10">storm </span>
   <span class="font10">survival </span>
   <span class="font10">synthetic </span>
   <span class="font10">titers </span>
   <span class="font10">toxic </span>
   <span class="font10">treating </span>
   <span class="font10">variability </span>
   <span class="font10">zoonotic </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">&amp;lt; </span>
   <span class="font10">(Barnard </span>
   <span class="font10">(Cao </span>
   <span class="font10">(Chen </span>
   <span class="font10">(IC </span>
   <span class="font10">(de </span>
   <span class="font10">-acetamido-Î±- </span>
   <span class="font10">./B----.- </span>
   <span class="font10">./NEJMoa </span>
   <span class="font10">./vir..- </span>
   <span class="font10">A.et </span>
   <span class="font10">BALB/c </span>
   <span class="font10">Barnard </span>
   <span class="font10">Biol. </span>
   <span class="font10">COVID-, </span>
   <span class="font10">Chem. </span>
   <span class="font10">Convalescent </span>
   <span class="font10">Despite </span>
   <span class="font10">Enzymes </span>
   <span class="font10">FDA-approved </span>
   <span class="font10">Furthermore, </span>
   <span class="font10">GRFT </span>
   <span class="font10">GS- </span>
   <span class="font10">Gen. </span>
   <span class="font10">HIV, </span>
   <span class="font10">Immunol.â€". </span>
   <span class="font10">L.et </span>
   <span class="font10">MERS </span>
   <span class="font10">Microbiol. </span>
   <span class="font10">Ongoing </span>
   <span class="font10">Perlman, </span>
   <span class="font10">Phe-Phe </span>
   <span class="font10">Research </span>
   <span class="font10">Rev.â€". </span>
   <span class="font10">Ribavirin </span>
   <span class="font10">SSAAE </span>
   <span class="font10">Treatment </span>
   <span class="font10">Umifenovir </span>
   <span class="font10">United </span>
   <span class="font10">Viral </span>
   <span class="font10">Wang </span>
   <span class="font10">Yao </span>
   <span class="font10">about </span>
   <span class="font10">act </span>
   <span class="font10">action </span>
   <span class="font10">additional </span>
   <span class="font10">affecting </span>
   <span class="font10">angiotensin-converting </span>
   <span class="font10">animals </span>
   <span class="font10">another </span>
   <span class="font10">anti-CoV </span>
   <span class="font10">anti-inflammatory </span>
   <span class="font10">approved </span>
   <span class="font10">assay </span>
   <span class="font10">attachment </span>
   <span class="font10">basis </span>
   <span class="font10">best </span>
   <span class="font10">better </span>
   <span class="font10">blocks </span>
   <span class="font10">bold </span>
   <span class="font10">capable </span>
   <span class="font10">chronic </span>
   <span class="font10">clearance </span>
   <span class="font10">collaborators </span>
   <span class="font10">compared </span>
   <span class="font10">complex </span>
   <span class="font10">considered </span>
   <span class="font10">contact </span>
   <span class="font10">contrasting </span>
   <span class="font10">coronavirus.J. </span>
   <span class="font10">coronavirus: </span>
   <span class="font10">courier; </span>
   <span class="font10">coworkers </span>
   <span class="font10">currently </span>
   <span class="font10">damage </span>
   <span class="font10">developed </span>
   <span class="font10">dipeptide </span>
   <span class="font10">docking </span>
   <span class="font10">drugs, </span>
   <span class="font10">east </span>
   <span class="font10">em; </span>
   <span class="font10">emphasize </span>
   <span class="font10">encompassing </span>
   <span class="font10">enzymatic </span>
   <span class="font10">enzymes </span>
   <span class="font10">evaluating </span>
   <span class="font10">evaluation </span>
   <span class="font10">even </span>
   <span class="font10">fusion </span>
   <span class="font10">genomic </span>
   <span class="font10">group </span>
   <span class="font10">having </span>
   <span class="font10">higher </span>
   <span class="font10">impair </span>
   <span class="font10">including </span>
   <span class="font10">infections, </span>
   <span class="font10">interactions </span>
   <span class="font10">invasive </span>
   <span class="font10">leading </span>
   <span class="font10">less </span>
   <span class="font10">literature </span>
   <span class="font10">mLâ€"), </span>
   <span class="font10">malaria </span>
   <span class="font10">models </span>
   <span class="font10">molecule </span>
   <span class="font10">mouse </span>
   <span class="font10">need </span>
   <span class="font10">neutralizing </span>
   <span class="font10">observational </span>
   <span class="font10">ongoing </span>
   <span class="font10">options </span>
   <span class="font10">pathogenesis </span>
   <span class="font10">pathologies </span>
   <span class="font10">pathways </span>
   <span class="font10">period </span>
   <span class="font10">placebo-controlled </span>
   <span class="font10">possesses </span>
   <span class="font10">production </span>
   <span class="font10">proposed </span>
   <span class="font10">proteases </span>
   <span class="font10">pt;} </span>
   <span class="font10">public </span>
   <span class="font10">recently, </span>
   <span class="font10">region </span>
   <span class="font10">replicative </span>
   <span class="font10">safety </span>
   <span class="font10">scaffold </span>
   <span class="font10">species </span>
   <span class="font10">spread </span>
   <span class="font10">step </span>
   <span class="font10">strategies </span>
   <span class="font10">study, </span>
   <span class="font10">surface </span>
   <span class="font10">symptoms, </span>
   <span class="font10">system </span>
   <span class="font10">tested </span>
   <span class="font10">therapies </span>
   <span class="font10">they </span>
   <span class="font10">those </span>
   <span class="font10">through </span>
   <span class="font10">tolerated </span>
   <span class="font10">treatments </span>
   <span class="font10">use, </span>
   <span class="font10">ventilation </span>
   <span class="font10">what </span>
   <span class="font10">without </span>
  </p>
 </body>
</html>
